Southern Research Institute

Organization Overview

Southern Research Institute is located in Birmingham, AL. The organization was established in 1945. According to its NTEE Classification (U33) the organization is classified as: Chemistry & Chemical Engineering, under the broad grouping of Science & Technology and related organizations. As of 12/2021, Southern Research Institute employed 491 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Southern Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.

For the year ending 12/2021, Southern Research Institute generated $85.7m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 3.5% each year. All expenses for the organization totaled $77.1m during the year ending 12/2021. You can explore the organizations financials more deeply in the financial statements section below.

Mission & Program ActivityExcerpts From the 990T Filing

TAX YEAR

2021

Describe the Organization's Mission:

Part 3 - Line 1

TO OFFER RESEARCH & TECHNOLOGY SERVICES TO SUPPORT INDUSTRY AND FEDERAL GOVERNMENT AGENCIES.

Describe the Organization's Program Activity:

DRUG DEVELOPMENT PROVIDES DRUG DISCOVERY AND PRE-CLINICAL DRUG DEVELOPMENT TO PHARMACEUTICAL AND BIOTECHNOLOGY ON AN OUTSOURCED BASIS. SOUTHERN RESEARCH INSTITUTE HAS CAPABILITIES IN ALL PHASES OF THE EARLY-STAGE DRUG DISCOVERY AND DEVELOPMENT PROCESS AND PROVIDES CLIENTS WITH COMPREHENSIVE SERVICES AND SUPPORT TO ASSIST THEM IN STREAMLINING THEIR CUSTOM DRUG DISCOVERY AND DEVELOPMENT PROGRAMS. SOME OF SOUTHERN RESEARCH INSTITUTE'S SIGNIFICANT PRE-CLINICAL RESEARCH ACCOMPLISHMENTS INCLUDE: DEMONSTRATED THE EFFICACY OF COMBINATION CHEMOTHERAPY IN MICE, LEADING THE WAY FOR THE DEVELOPMENT OF THERAPEUTIC APPROACHES WITH IMPROVED CLINICAL OUTCOMES IN CERTAIN CANCERS, PERFORMED PRE-CLINICAL DRUG DEVELOPMENT EVALUATIONS AND ANALYSES ON APPROXIMATELY HALF OF THE FDA-APPROVED CANCER THERAPEUTICS CURRENTLY ON THE MARKET, AND CONTRIBUTED TO THE DEVELOPMENT OF THE FIRST DRUG DELIVERY TECHNOLOGY FOR THE EXTENDED RELEASE OF SYNTHETIC AGENTS THAT PROMOTE THE TREATMENT OF PROSTATE CANCER.


THE ENGINEERING DIVISION DEVELOPS ENGINEERING SOLUTIONS TO COMPLEX PROBLEMS THROUGH CHARACTERIZING THE MECHANICAL, THERMAL, PHYSICAL, AND CHEMICAL PROPERTIES OF ADVANCED MATERIALS. THE ENGINEERING DIVISION IS ALSO DEVELOPING NEW, LOW-COST PROCESSES TO PRODUCE CARBON/CARBON AND POLYMER MATRIX COMPOSITE MATERIALS AND AEROGELS (ULTRA-LIGHT FOAM), AS WELL AS PROCESSING METHODS TO FABRICATE THESE MATERIALS FOR A WIDE VARIETY OF APPLICATIONS FROM AUTOMOTIVE AND RECREATIONAL PRODUCTS TO THE MOST ADVANCED AEROSPACE APPLICATIONS. SOUTHERN RESEARCH INSTITUTE ALSO PROVIDES ENVIRONMENTAL RESEARCH AND SERVICES TO GOVERNMENT, INDUSTRY, AND PRIVATE INSTITUTIONS. THE RESEARCH HAS LED TO THE DEVELOPMENT OF NEW TEST METHODS AND INSTRUMENTS, THE IMPROVEMENT OF PROCESS AND EMISSION CONTROL TECHNOLOGIES, SOLUTIONS TO DAUNTING NEW ENVIRONMENTAL CHALLENGES, AND OTHER IMPORTANT CONTRIBUTIONS TO ENVIRONMENTAL SCIENCES.


DRUG DISCOVERY HAS ACCOMPLISHED INNOVATIVE RESEARCH IN THE AREAS OF CANCER, INFECTIOUS DISEASE, AND NEUROSCIENCE. WITH A FOCUS ON THE DISCOVERY OF NEW, SMALL-MOLECULE THERAPEUTICS AND THE UNDERSTANDING OF HOW THESE MOLECULES WORK, DRUG DISCOVERY CARRIES OUT TRANSLATIONAL SCIENCE DESIGNED TO INVENT SMALL MOLECULES AND ADVANCE THEM FROM THE DESIGN STAGE TO THE CLINIC. GOVERNMENT FUNDING SUPPORTS OUR EFFORTS IN PIONEERING NEW SCIENTIFIC AREAS OF DRUG DISCOVERY. THE DRUG DISCOVERY STAFF PROVIDES EXPERTISE IN MEDICINAL CHEMISTRY, MOLECULAR BIOLOGY, BIOCHEMISTRY, AND HIGH-THROUGHPUT SCREENING TECHNOLOGIES, ALL FOCUSED ON MAKING DISCOVERIES THAT WILL CONTRIBUTE TO IMPROVING HUMAN HEALTH. THE DRUG DISCOVERY TEAM HAS BEEN VERY EFFECTIVE IN ITS EFFORTS AND HAS DISCOVERED MORE THAN 20 DRUGS THAT HAVE ENTERED CLINICAL TRIALS AND SIX DRUGS THAT HAVE BEEN APPROVED BY THE FDA FOR USE IN THE TREATMENT OF CANCER.


SOUTHERN RESEARCH'S STEM EDUCATION OUTREACH PROGRAM IS INVOLVED IN A WIDE VARIETY OF PROGRAMS THAT IMPACT STUDENTS AND TEACHERS IN ALABAMA. THE MISSION OF SR'S STEM PROGRAM IS TO ENHANCE 6TH 12TH GRADE STEM EDUCATION BY DRAWING UPON THE EXPERTISE AND SCHOLARLY CONTRIBUTIONS OF THE SOUTHERN RESEARCH COMMUNITY. WE AIM TO DEFINE AND EXEMPLIFY EFFECTIVE STEM EDUCATION TO MAXIMIZE STUDENTS' READINESS TO EXCEL IN A RAPIDLY CHANGING WORLD. WE ARE WORKING TO ACHIEVE OUR EDUCATION MISSION BY ENGAGING STUDENTS AND TEACHERS IN STEM ACTIVITIES THROUGH SUMMER LEARNING PROGRAMS, FIELD TRIPS, AFTER-SCHOOL PROGRAMING, STEM COMPETITIONS AND SCIENCE FAIRS, INTERNSHIPS, AND PROFESSIONAL DEVELOPMENT WORKSHOPS FOR STEM EDUCATORS. OUR PRIMARY OBJECTIVE IS TO EMBOLDEN STUDENTS WHO POSSESS A PASSION FOR INNOVATION AND DISCOVERY TO PURSUE THEIR INTERESTS AND STRENGTHEN THE STEM COMMUNITY. SOUTHERN RESEARCH IS COMMITTED TO FOSTERING CREATIVITY AND IMPACTING THE FUTURE GENERATION.


Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.

Outside Vendors & Contractors

Vendor Name (Service)Compensation
Materials Research And Design Inc
Ee Structural Design And Analysis
$639,780
University Of Alabama At Birmingham
Steam And Contract Services
$1,859,148
Regions Bank
Financial Services
$829,769
Tiaa Cref
Financial Services
$3,736,190
Flir Commercial Systems
Design And Productions Of Thermal Imagin
$652,468
View All Vendors

Financial Statements

Statement of Revenue
Federated campaigns$0
Membership dues$0
Fundraising events$0
Related organizations$0
Government grants $0
All other contributions, gifts, grants, and similar amounts not included above$155,458
Noncash contributions included in lines 1a–1f $0
Total Revenue from Contributions, Gifts, Grants & Similar$155,458
Total Program Service Revenue$80,785,233
Investment income $418,953
Tax Exempt Bond Proceeds $0
Royalties $0
Net Rental Income $29,100
Net Gain/Loss on Asset Sales $4,257,517
Net Income from Fundraising Events $0
Net Income from Gaming Activities $0
Net Income from Sales of Inventory $0
Miscellaneous Revenue$0
Total Revenue $85,654,710

Grants Awarded

Over the last fiscal year, Southern Research Institute has awarded $26,400 in support to 4 organizations.

Grant RecipientAmount

UNITED WAY OF CENTRAL ALABAMA

Org PageRecipient Profile

Birmingham, AL

PURPOSE: GENERAL SUPPORT

$10,000

HOLY FAMILY CRISTO REY CATHOLIC HIGH SCHOOL INC

Org PageRecipient Profile

Birmingham, AL

PURPOSE: GENERAL SUPPORT

$6,400

AMERICAN CANCER SOCIETY INC

Org PageRecipient Profile

Kennesaw, GA

PURPOSE: GENERAL SUPPORT

$5,000

ECONOMIC DEVELOPMENT PARTNERSHIP OF ALABAMA INC

Org PageRecipient Profile

Birmingham, AL

PURPOSE: GENERAL SUPPORT

$5,000
View Grant Profile

Grants Recieved

Over the last fiscal year, we have identified 3 grants that Southern Research Institute has recieved totaling $232,944.

Awarding OrganizationAmount
Michael J Fox Foundation For Parkinsons Research

New York, NY

PURPOSE: PARKINSON'S RESEARCH

$133,097
Louise Maytag Smith Charitable Tr

Montgomery, AL

PURPOSE: LIFE SCIENCES RESEARCH

$74,847
Breast Cancer Research Foundation Of Alabama

Birmingham, AL

PURPOSE: THE FUNDS ARE USED FOR EXPANDING INNOVATIVE CANCER RESEARCH AND FOR PURCHASING NECESSARY SUPPLIES NEEDED FOR THIS RESEARCH.

$25,000
View Grant Recipient Profile

Endowment Analysis

Beg. Balance$12,226,041
Earnings$1,670,896
Admin Expense$30,937
Other Expense$557,524
Ending Balance$13,308,476

Create an account to unlock the data you need.

or